NCT07029282View on ClinicalTrials.gov

The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes

PHASE3RecruitingINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Newborn HealthMultiple Micronutrient Deficiencies During PregnancyNutrition During PregnancyAdaptive TrialPostnatal GrowthNeurodevelopment Outcome
Interventions
DIETARY_SUPPLEMENT

MMS

Pregnant women in this arm will receive 6gms of MMS (UNIMAPP MMS) in a ready to use sachet form which includes 15 nutrients.

DRUG

MMS Plus

Pregnant women in this arm will receive 6gms of MMS Plus in a ready to use sachet form which includes 18 nutrients.

DIETARY_SUPPLEMENT

IFA

Pregnant women in this arm will receive 6gms of IFA (Iron/Folic Acid) in a ready to use sachet form which includes 2 nutrients.

Trial Locations (1)

Unknown

RECRUITING

Peri-Urban Slums of Karachi (Ali Akber Shah, Bhains Colony), Karachi

All Listed Sponsors
collaborator

Vital Pakistan Trust

OTHER

lead

Aga Khan University

OTHER